Inventor
KIM JONG MOOK
KR21 patents
⚠️ This page may combine multiple inventors who share the name “KIM JONG MOOK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VIROMED CO LTD
5 patentsUS7812146B2Oct 12, 2010
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
VIROMED CO LTD8 citations82
US7745174B2Jun 29, 2010
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
VIROMED CO LTD8 citations82
US7175840B2Feb 13, 2007
Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
VIROMED CO LTD12 citations82
US7838505B2Nov 23, 2010
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
VIROMED CO LTD4 citations71
US7585943B2Sep 8, 2009
Compositions and methods for fusion protein separation
VIROMED CO LTD6 citations70
KIM JONG-MOOK
3 patentsUS8338385B2Dec 25, 2012
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
KIM JONG-MOOK5 citations71
US8389492B2Mar 5, 2013
Lyophilized DNA formulations for enhanced expression of plasmid DNA
KIM JONG-MOOK3 citations56
US8772021B2Jul 8, 2014
Expression vector for animal cell comprising at least one copy of MAR DNA sequences at the 3′ terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector
KIM JONG-MOOK1 citations45
VIROMED LTD
2 patentsCELLTRION INC
2 patentsUS9834594B2Dec 5, 2017
Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
CELLTRION INC2 citations71
US11007136B2May 18, 2021
Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllum
CELLTRION INC0 citations58